000 02282 a2200637 4500
005 20250514010135.0
264 0 _c20010920
008 200109s 0 0 eng d
022 _a0732-183X
024 7 _a10.1200/JCO.2001.19.17.3771
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStewart, A K
245 0 0 _aPurging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial.
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_cSep 2001
300 _a3771-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntigens, CD34
_xanalysis
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aBone Marrow Purging
_xmethods
650 0 4 _aCombined Modality Therapy
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMultiple Myeloma
_ximmunology
650 0 4 _aNeoplastic Cells, Circulating
_ximmunology
650 0 4 _aPolymerase Chain Reaction
650 0 4 _aProportional Hazards Models
650 0 4 _aSurvival Rate
700 1 _aVescio, R
700 1 _aSchiller, G
700 1 _aBallester, O
700 1 _aNoga, S
700 1 _aRugo, H
700 1 _aFreytes, C
700 1 _aStadtmauer, E
700 1 _aTarantolo, S
700 1 _aSahebi, F
700 1 _aStiff, P
700 1 _aMeharchard, J
700 1 _aSchlossman, R
700 1 _aBrown, R
700 1 _aTully, H
700 1 _aBenyunes, M
700 1 _aJacobs, C
700 1 _aBerenson, R
700 1 _aWhite, M
700 1 _aDiPersio, J
700 1 _aAnderson, K C
700 1 _aBerenson, J
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 19
_gno. 17
_gp. 3771-9
856 4 0 _uhttps://doi.org/10.1200/JCO.2001.19.17.3771
_zAvailable from publisher's website
999 _c11456925
_d11456925